Skip to content
ClinCalc Pro
Menu
Oral ferrous iron

Ferrous fumarate

Brand names: Galfer, Fersaday, Fersamal

Used in: Anaemia

Ferrous fumarate is an oral ferrous (iron[II]) salt used to treat and prevent iron-deficiency anaemia.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It provides elemental iron in the absorbable ferrous form, which is taken up in the duodenum and incorporated into haemoglobin to support erythropoiesis.

Prescribing in practice

  • Iron salts are a leading cause of accidental poisoning fatalities in young children, so keep all preparations well out of reach and counsel on safe storage.
  • Absorption is reduced by tea, antacids, calcium, and by chelation with tetracyclines, quinolones, levothyroxine and bisphosphonates, which should be separated in time.
  • Gastrointestinal upset, constipation and dark stools are common and may improve by taking the dose with or after food at the cost of slightly reduced absorption.

Monitoring

Check haemoglobin and iron indices after a few weeks to confirm an adequate response, continuing treatment for a period after normalisation to replenish stores.

Counselling the patient

  • Stools may turn black; this is harmless and expected.
  • Keep iron tablets away from children as overdose can be dangerous.
  • Avoid taking with tea, milk or indigestion remedies at the same time of day.

Evidence & guidelines

NICE guidance supports oral ferrous salts as first-line treatment for iron-deficiency anaemia, with parenteral iron reserved for intolerance or malabsorption.

Reference: NICE CKS; Stoffel et al 2019 (alternate-day dosing); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.